Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
Мақола

Lack of anti-GOR antibody among subjects with GB virus C/hepatitis G virus RNA

Tatsunori NakanoSecond Department of Medicine, Nagoya City University Medical School, Mizuho, Nagoya, JapanMasashi MizokamiSecond Department of Medicine, Nagoya City University Medical School, Nagoya, JapanKun CaoSecond Department of Medicine, Nagoya City University Medical School, Nagoya, JapanSeiji NoguchiSecond Department of Medicine, Kurume University School of Medicine, Kurume, JapanM SataSecond Department of Medicine, Kurume University School of Medicine, Kurume, JapanYoung-Min ParkDepartment of Internal Medicine, Kangnam St. Mary's Hospital, Catholic University Medical College, Seoul, KoreaBoo‐Sung KimDepartment of Internal Medicine, Kangnam St. Mary's Hospital, Catholic University Medical College, Seoul, KoreaTsendsuren OyunsurenInstitute of Biotechnology, Academy of Science, Ulaanbaatar, MongoliaLeila Beltrão PereiraDepartment of Gastroenterology, University of Pernambuco, Recife, BrazilRuslan RuzibakievInstitute of Immunology, Academy of Science, Tashkent, UzbekistanVladimir GurtsevitchMasanori HayamiInstitute for Virus Research, Kyoto University, Kyoto, Japan
ABI

Аннотация

Homologies were sought between the putative amino acid sequences of GB virus C/hepatitis G virus (GBV-C/HGV) and the GOR epitope or the liver/kidney microsome-1 (LKM-1) epitope, which share partial sequence identity with the hepatitis C virus (HCV) polyprotein. Anti-GOR antibody (anti-GOR) was assayed among 100 subjects with GBV-C/HGV RNA. Twenty-one and 25 subjects were coinfected with hepatitis B virus (HBV) or HCV, respectively. Homologies were found between the NS5 or E2 polyproteins of GBV-C/HGV and the GOR epitope or the LKM-1 epitope, respectively. These segments of GBV-C/HGV polyproteins sharing identity with the GOR or the LKM-1 epitope were well conserved among three genotypes of GBV-C/HGV. However, only 1 of 55 subjects (1.8%) with GBV-C/HGV RNA, but not with HBV or HCV, was positive for anti-GOR. The positivity for anti-GOR among the group with GBV-C/HGV RNA alone was significantly lower than that among the groups with HCV RNA (P < 0.01 and P < 0.05, respectively). Only 2 of 55 subjects (3.6%) with GBV-C/HGV RNA alone exhibited elevation of alanine aminotransferase. The incidence of liver dysfunction among the group with GBV-C/HGV RNA alone was significantly lower than the incidence among the groups with GBV-C/HGV RNA and hepatitis B surface antigen (HBsAg) or HCV RNA (P< 0.01 and P< 0.01, respectively). These data indicate that 1) there is no association between GBV-C/HGV infection and the presence of anti-GOR, and 2) GBV-C/HGV infection is not related to chronic liver dysfunction.

Ҳали таржима қилинмаган

Мавзулар

Идентификаторлар

Иқтибослар ва манбалар

Кўрсаткичлар — AkademScholar · Тез орада